Alembic Pharma shares hit 52-week high after Gujarat plant clears USFDA inspection

The maker of pharmaceutical inputs and bulk drugs said there was no Form 483 observation after the USFDA inspection of its plant in Gujarat this week.

Leave a Reply

Your email address will not be published. Required fields are marked *